Fig. 4
From: Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer
Boxplot of the methylation ratio in normal controls (n = 266) and stage I–IV CRC samples with tumor burden after propensity score matching (n = 5, 23, 69, 169 for stage I-IV CRC samples, respectively)